Dr. Robert Shin, Professor of Neurology at Georgetown University in Washington, D.C. and the Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center discusses multiple sclerosis (MS), relapsing forms of MS (RMS), symptoms, and the new FDA approved Kesimpta® (ofatumumab), the first and only self-administered injection for the treatment of RMS. He is joined by Kerry, a patient with RMS. Kerry is not currently taking Kesimpta®.